FIELD: peptide synthesis. SUBSTANCE: invention provides new peptide with general formula I: (I) wherein R is hydrogen, lower alkyl, or lower acyl; X heteroaromatic amino acid residue; and n=1 or 2; on condition that, when residue RNHCH(COOH)(CH2)nCO- is glutamic acid residue (n= 2), then X has stereo configuration different from that at alpha-carbon atom of glutamic acid having immuno-simulating activity. Preparation having such activity and containing peptide I (0.001 to 0.01 %) and special additives (the balance) is also provided. EFFECT: enlarged choice of immuno-simulating peptides. 2 cl, 11 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
POLYPEPTIDE SHOWING IMMUNOMODULATING ACTIVITY | 1995 |
|
RU2091389C1 |
IMMUNOSTIMULATING AGENT AND A PREPARATION BASED ON THEREOF | 1995 |
|
RU2120298C1 |
PEPTIDE COMPOSITION FOR ANTIBODY ASSAY TO HEPATITIS C VIRUS | 1994 |
|
RU2071350C1 |
DIAGNOSTIC COMPOSITION FOR IDENTIFICATION OF SYPHILIS AND TEST-SYSTEM "AKVASIF" ON ITS BASE | 1998 |
|
RU2137138C1 |
COMPOSITION FOR HEPATITIS C DIAGNOSIS | 1994 |
|
RU2071349C1 |
BIOLOGICALLY ACTIVE PEPTIDE COMPLEXES | 2011 |
|
RU2470031C2 |
PEPTIDE ENHANCING RESISTANCE OF CAPILLARIES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2295970C1 |
METHOD OF DETECTION OF ANTIBODY TO HEPATITIS VIRUS C NUCLEAR PROTEIN | 1997 |
|
RU2133622C1 |
TEST SYSTEM FOR DETECTING ANTIBODIES TO NUCLEAR PROTEIN OF HEPATITIS C OF IGM CLASS | 1997 |
|
RU2142134C1 |
PHARMACEUTICAL COMPOSITION ON BASIS OF PEPTIDE POSSESSING ANTITUMORAL ACTION | 2007 |
|
RU2362579C1 |
Authors
Dates
1999-12-20—Published
1997-12-25—Filed